Predictive Analytics and AI for Pancreatic Cancer Screening - A Data Driven Approach to Early Detection

Selected as one of the most critical areas of study in AI informatics, pancreatic cancer, if not treated, has extremely high mortality rates. In this study, we analyze how health informatics along with AI could potentially increase the rates of diagnoses. By making use of the Deep Learning and Machine Learning Recurrent Neural Networks Proficy, which has the ability to parse complex, sphered medical images, genetic information, and even electronic health records, we wish to tackle aid diagnosis. AI has the capability to accurately identify early stage indicators which humans struggle with. This immense capability enables computerized systems to promise higher levels of proof to be fully confident that the indicator is risk prone and controlling it as early as possible to prevent danger. Doing so has the least amount of risks, the AI’s preliminary actions would greatly reduce incorrect screening and improve sensitivity and specificity indexes. Studies show that AI enhances diagnostic and therapeutic accuracy augmentably while decreasing the amount of time diagnosed, which in turn would help with lowered death rates. Further studies will figure out how to reflect these models in all societies and clauses to maximize aid potential for treating pancreatic cancer.